Akebia Therapeutics, Inc. (AKBA) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
AKBA Historical Performance
Short-Term Returns
AKBA Stock Price Trajectory (2014–2026)
As of May 8, 2026, Akebia Therapeutics, Inc. (AKBA) trades at $1.18, representing a -52.0% return over the past year. The stock has delivered a -62.2% total return over five years (-17.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $31.00 on June 20, 2014. From this peak, AKBA has corrected -96.2%, currently trading 42% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers FOLD (+137.9% 1Y), PTGX (+129.4% 1Y), and CYCN (-8.2% 1Y), AKBA has underperformed the peer group average. Compare AKBA vs FOLD →
AKBA Historical Price Data (2025–2026)
Showing 30 of 3,053 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.15 | 1.23 | 1.13 | 1.18 | 11.70M | -20.27% |
| 2026-05-06 | 1.48 | 1.53 | 1.46 | 1.48 | 3.68M | +2.07% |
| 2026-05-05 | 1.53 | 1.53 | 1.43 | 1.45 | 2.15M | -3.33% |
| 2026-05-04 | 1.41 | 1.53 | 1.41 | 1.50 | 3.26M | +7.14% |
| 2026-05-01 | 1.40 | 1.44 | 1.38 | 1.40 | 2.52M | +1.45% |
| 2026-04-30 | 1.39 | 1.41 | 1.36 | 1.38 | 1.07M | +1.47% |
| 2026-04-29 | 1.41 | 1.41 | 1.35 | 1.36 | 2.18M | -4.23% |
| 2026-04-28 | 1.42 | 1.46 | 1.41 | 1.42 | 1.51M | 0.00% |
| 2026-04-27 | 1.43 | 1.51 | 1.42 | 1.42 | 2.66M | -0.70% |
| 2026-04-24 | 1.42 | 1.45 | 1.41 | 1.43 | 2.37M | 0.00% |
| 2026-04-23 | 1.43 | 1.44 | 1.39 | 1.43 | 2.15M | +0.70% |
| 2026-04-22 | 1.42 | 1.45 | 1.40 | 1.42 | 1.49M | +0.71% |
| 2026-04-21 | 1.45 | 1.46 | 1.40 | 1.41 | 1.70M | -1.40% |
| 2026-04-20 | 1.41 | 1.45 | 1.40 | 1.43 | 1.95M | +1.78% |
| 2026-04-17 | 1.38 | 1.45 | 1.32 | 1.41 | 4.02M | +4.07% |
| 2026-04-16 | 1.54 | 1.56 | 1.35 | 1.35 | 5.19M | -12.90% |
| 2026-04-15 | 1.57 | 1.59 | 1.53 | 1.55 | 1.97M | -0.64% |
| 2026-04-14 | 1.48 | 1.56 | 1.47 | 1.56 | 2.21M | +6.12% |
| 2026-04-13 | 1.40 | 1.47 | 1.39 | 1.47 | 1.70M | +5.00% |
| 2026-04-10 | 1.41 | 1.46 | 1.39 | 1.40 | 1.96M | -0.71% |
| 2026-04-09 | 1.42 | 1.45 | 1.41 | 1.41 | 1.22M | -1.40% |
| 2026-04-08 | 1.41 | 1.47 | 1.40 | 1.43 | 2.50M | +3.62% |
| 2026-04-07 | 1.33 | 1.39 | 1.30 | 1.38 | 2.35M | +4.55% |
| 2026-04-06 | 1.38 | 1.40 | 1.32 | 1.32 | 2.34M | -4.35% |
| 2026-04-02 | 1.39 | 1.40 | 1.35 | 1.38 | 1.77M | -2.13% |
| 2026-04-01 | 1.40 | 1.46 | 1.40 | 1.41 | 1.76M | +1.44% |
| 2026-03-31 | 1.36 | 1.40 | 1.34 | 1.39 | 1.87M | +5.30% |
| 2026-03-30 | 1.31 | 1.35 | 1.30 | 1.32 | 2.61M | -1.49% |
| 2026-03-27 | 1.37 | 1.38 | 1.32 | 1.34 | 2.49M | -3.60% |
| 2026-03-26 | 1.39 | 1.44 | 1.36 | 1.39 | 1.78M | 0.00% |
See AKBA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AKBA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AKBA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAKBA — Frequently Asked Questions
Quick answers to the most common questions about buying AKBA stock.
How has AKBA stock performed recently?
AKBA declined -52.0% over the past year, below its 5-year annualized CAGR of -17.7%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is AKBA's all-time high price?
Akebia Therapeutics, Inc. reached $31.00 on 2014-06-20. The 52-week high is $4.08. Current 1-year return of -52.0% places the stock further from historical peaks.
Where can I download AKBA historical price data?
This page provides AKBA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.